К вопросу о рациональном выборе топической терапии при атопическом дерматите

Дворянкова Е.В., Корсунская И.М., Сакания Л.Р., Невозинская З.А. К вопросу о рациональном выборе топической терапии при атопическом дерматите. Consilium Medicum. Pediatrics (Suppl.). 2015; 1: 70–74.

________________________________________________

Dvoryankova E.V., Korsunskaya I.M.*, Sakaniya L.R., Nevozinskaya Z.A. On the issue of rational choice of topical therapy for atopic dermatitis. Consilium Medicum. Pediatrics (Suppl.). 2015; 1: 70–74.

Читать PDF

Аннотация

В статье приведены современные данные о механизмах развития атопического дерматита, рассматриваются разные аспекты клинических проявлений атопического дерматита у детей разного возраста, а также предлагаются подходы к терапии атопического дерматита у детей с учетом тех или иных кожных проявлений заболевания.

Ключевые слова: атопический дерматит, лечение дерматита, метилпреднизолона ацепонат.

________________________________________________

The paper presents the current data on the mechanisms of atopic dermatitis; also are considered different aspects of the clinical manifestations of the disease in children of different ages, and some approaches are suggested for the treatment of atopic dermatitis in children, taking into account the various cutaneous manifestations.

Key words: atopic dermatitis, dermatitis treatment, methylprednisolone aceponate.

Полный текст

Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью Авторизуйтесь или зарегистрируйтесь.

Список литературы

1. Amestejani M, Salehi BS, Vasigh M et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol 2012; 11: 327–30.
2. Kapoor R, Menon C, Hoffstad O et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008; 58: 68–73.
3. Weber MB, Lorenzini D, Reinehr CP, Lovato B. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil. An Bras Dermatol 2012; 87: 697–702.
4. Kiebert G, Sorensen SV, Revicki D et al. Atopic dermatitisis associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151–8.
5. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233–46.
6. Dold S, Wjst M, von Mutius E et al. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992; 67: 1018–22.
7. Carlsen BC, Thyssen JP, Menne T et al. Association between filaggrin null mutations and concomitant atopic dermatitis and contact allergy. Clin Exp Dermatol 2011; 36: 467–72.
8. Schneider L, Tilles S, Lio P et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol 2013; 131: 295–9.
9. Freiberg IM, Eisen AZ, Wolff K et al. Fitzpatrick's Dermatology in general medicine. 6th ed. V. 1. New York: McGraw Hill, 2003; p. 1464.
10. Froebe CL, Simion A, Ohlmeyer H et al. Prevention od stratum corneum lipid phase transitions in vitro by glycerol – an alternative mechanism for skin moisturisation. J Soc Cosmet Chem 1990: 41: 51–65
11. Йоффе Д.В. Жиры. В кн.: Химическая энциклопедия. М.: Советская энциклопедия, 1990; с. 155–7. / Ioffe D.V. Zhiry. V kn.: Khimicheskaia entsiklopediia. M.: Sovetskaia entsiklopediia, 1990; s. 155–7. [in Russian]
12. Fulton J Jr. Comedogenicity and irritancy of commonly used ingredients. J Soc Cosmet Сhem 1989; 40: 321–33.
13. Nguyen SH, Dang TP, Maibach HI. Comedogenicity in rabbit: some cosmetic ingredients/vehicles. Cutan Ocul Toxicol 2007; 26: 287–92.
14. Блюм-Пейтави У. Особенности течения и дифференциальная диагностика атопического дерматита у детей. Consilium Medicum. Педиатрия (Прил.). 2014; 1: 27–30. / Blium-Peitavi U. Osobennosti techeniia i differentsial'naia diagnostika atopicheskogo dermatita u detei. Consilium Medicum. Pediatriia (Pril.). 2014; 1: 27–30. [in Russian]

________________________________________________

1. Amestejani M, Salehi BS, Vasigh M et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol 2012; 11: 327–30.
2. Kapoor R, Menon C, Hoffstad O et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008; 58: 68–73.
3. Weber MB, Lorenzini D, Reinehr CP, Lovato B. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil. An Bras Dermatol 2012; 87: 697–702.
4. Kiebert G, Sorensen SV, Revicki D et al. Atopic dermatitisis associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151–8.
5. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233–46.
6. Dold S, Wjst M, von Mutius E et al. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992; 67: 1018–22.
7. Carlsen BC, Thyssen JP, Menne T et al. Association between filaggrin null mutations and concomitant atopic dermatitis and contact allergy. Clin Exp Dermatol 2011; 36: 467–72.
8. Schneider L, Tilles S, Lio P et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol 2013; 131: 295–9.
9. Freiberg IM, Eisen AZ, Wolff K et al. Fitzpatrick's Dermatology in general medicine. 6th ed. V. 1. New York: McGraw Hill, 2003; p. 1464.
10. Froebe CL, Simion A, Ohlmeyer H et al. Prevention od stratum corneum lipid phase transitions in vitro by glycerol – an alternative mechanism for skin moisturisation. J Soc Cosmet Chem 1990: 41: 51–65
11. Ioffe D.V. Zhiry. V kn.: Khimicheskaia entsiklopediia. M.: Sovetskaia entsiklopediia, 1990; s. 155–7. [in Russian]
12. Fulton J Jr. Comedogenicity and irritancy of commonly used ingredients. J Soc Cosmet Сhem 1989; 40: 321–33.
13. Nguyen SH, Dang TP, Maibach HI. Comedogenicity in rabbit: some cosmetic ingredients/vehicles. Cutan Ocul Toxicol 2007; 26: 287–92.
14. Blium-Peitavi U. Osobennosti techeniia i differentsial'naia diagnostika atopicheskogo dermatita u detei. Consilium Medicum. Pediatriia (Pril.). 2014; 1: 27–30. [in Russian]

Авторы

Е.В.Дворянкова1, И.М.Корсунская*1, Л.Р.Сакания1, З.А.Невозинская2

1 ФГБУН Центр теоретических проблем физико-химической фармакологии РАН. 119991, Россия, Москва, Ленинский проспект, д. 38а, корп. 1;
2 ГБУЗ Московский научно-практический центр дерматовенерологии и косметологии Департамента здравоохранения г. Москвы. 119071, Россия, Москва, Ленинский проспект, д. 17
*marykor@bk.ru

________________________________________________

E.V.Dvoryankova1, I.M.Korsunskaya1, L.R.Sakaniya1, Z.A.Nevozinskaya2

1 Center for Theoretical Problems of Physicochemical Pharmacology. 119991, Russian Federation, Moscow, Leninskiy prospekt, d. 38a, korp. 1;
2 Moscow Scientific and Practical Center of Dermatology and Venereology and Cosmetology of the Department of Health of Moscow. 119071, Russian Federation, Moscow, Leninskiy prospekt, d. 17
*marykor@bk.ru

Назад к списку

Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.